Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2026-05-20 17:05:22 ET · period of report 2026-05-18 · accession 0001837798-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 17:05 | 2026-05-18 | AUPH | Robertson Stephen P. | CLO | A - Grant | $0.00 | +115.5K | 621.4K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | A | A | 115,541 | $0.00 | 621,402 | D | — | — | (F1) Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 115,541 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date. |